1,031 companies
AMPH
Amphastar Pharmaceuticals Inc
amphastar pharmaceuticals, inc., headquartered in rancho cucamonga, california, established in 1996, is a recognized specialty pharmaceutical company that uses state-of-the-art, cgmp compliant facilities to develop, manufacture, and market injectable and inhalation products.
California
NASDAQ
AMPE
Ampio Pharmaceuticals Inc
ampio pharmaceuticals inc (ampe) is a biotechnology company located in 5445 dtc pkwy, greenwood village, colorado, united states.
Colorado
NYSE
AMYT
Amryt Pharma Plc
Amryt Pharma PLC operates as a biopharmaceutical company.
United Kingdom
NASDAQ
AMLX
Amylyx Pharmaceuticals Inc
Amylyx Pharmaceuticals, Inc is a biopharmaceutical company headquartered in Cambridge, Massachusetts.
Massachusetts
NASDAQ
ANAB
AnaptysBio Inc
founded in 2005, anaptysbio, inc.
California
NASDAQ
ANEB
Anebulo Pharmaceuticals Inc
Anebulo Pharmaceuticals, Inc.
Texas
NASDAQ
AGGX
AngioGenex, Inc.
AngioGenex, Inc.
New York
OTC
ANIX
Anixa Biosciences Inc
itus develops and acquires patented technologies for the purposes of patent monetization and patent assertion.
California
NASDAQ
ANNX
Annexon Inc
our mission is to develop disease-modifying therapeutics for patients suffering from neurological disorders such as huntington’s disease and alzheimer’s disease by targeting complement-mediated neurodegeneration (cmnd).
California
NASDAQ
ANVS
Annovis Bio Inc
annovis bio, inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration.
Pennsylvania
NYSE
APLS
Apellis Pharmaceuticals Inc
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits.
Massachusetts
NASDAQ
APGN
Apexigen Inc
apexigen is a clinical-stage biopharmaceutical company discovering and developing innovative immuno-oncology therapeutics generated by apximab™, the company’s proprietary antibody drug discovery platform.
California
NASDAQ
Apexigen, Inc.
California
APLM
Apollomics Inc.
Apollomics is a clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer.
California
NASDAQ
AMTI
Applied Molecular Transport Inc.
applied molecular transport is developing a pipeline of transformative, targeted oral biological therapeutics that promise to redefine the future of biopharmaceuticals.
Delaware
NASDAQ
APLT
Applied Therapeutics Inc
applied therapeutics, inc.
New York
NASDAQ
APRE
Aprea Therapeutics Inc
annan naturvetenskaplig och teknisk forskning och utveckling
Pennsylvania
NASDAQ
APVO
Aptevo Therapeutics Inc
aptevo therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
Washington
NASDAQ
APTX
Aptinyx Inc.
welcome to our company page and thank you for your interest in aptinyx inc.
Illinois
NASDAQ
APM
Aptorum Group Ltd - Ordinary Shares
aptorum group limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers.
United Kingdom
NASDAQ